CUPR
Cuprina Holdings (Cayman) Ltd.
NASDAQ · Healthcare · Biotechnology · SG
$1.87
+0.00%Margins
Gross margin
-26.3%
EBITDA margin
-9793.8%
EBIT margin
-9867.6%
Net margin
-9508.7%
FCF margin
—
-119.0%
Return on equity
-70.7%
Return on assets
-112.7%
Return on invested capital
0.01x
Asset turnover
-$12.8M
Cash from operations
$0.35
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025